BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38504259)

  • 1. Urinary cadmium concentration is associated with the severity and clinical outcomes of COVID-19: a bicenter observational cohort study.
    Chiu LC; Lee CS; Hsu PC; Li HH; Chan TM; Hsiao CC; Kuo SC; Ko HW; Lin SM; Wang CH; Lin HC; Chu PH; Yen TH
    Environ Health; 2024 Mar; 23(1):29. PubMed ID: 38504259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent lymphocyte reduction and interleukin-6 levels are independently associated with death in patients with COVID-19.
    Xu Y; Wang N; Shen X; Liu X; Liu H; Liu Y
    Clin Exp Med; 2023 Nov; 23(7):3719-3728. PubMed ID: 37310657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 severity appears to be reduced in spring/summer.
    Sposato B; Serafini A; Simoncini E; Croci L; Guidoni C; Scalese M; Baratta P; Cresti A; Lacerenza LG; Lena F; Nencioni C; Spargi G; Perrella A;
    Epidemiol Prev; 2023; 47(1-2):34-46. PubMed ID: 36971236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric correlation of laboratory biomarkers to multiorgan failure outcome in hospitalized COVID-19 patients: a retrospective observational study.
    Ballini A; Cantore S; Serretiello E; Troiano G; Smimmo A; Dioguardi M; Spirito F; Sasso FC; De Vito D; Lo Muzio L; Di Domenico M
    Eur Rev Med Pharmacol Sci; 2023 Sep; 27(18):8962-8974. PubMed ID: 37782206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.
    Soto A; Krapp F; Vargas A; Cabrejos L; Argumanis E; García PL; Altamirano K; Montes M; Chacón-Uscamaita PR; García PJ
    Trials; 2021 May; 22(1):342. PubMed ID: 34001174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection.
    Ioannou GN; Locke E; Green P; Berry K; O'Hare AM; Shah JA; Crothers K; Eastment MC; Dominitz JA; Fan VS
    JAMA Netw Open; 2020 Sep; 3(9):e2022310. PubMed ID: 32965502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
    Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative.
    Bennett TD; Moffitt RA; Hajagos JG; Amor B; Anand A; Bissell MM; Bradwell KR; Bremer C; Byrd JB; Denham A; DeWitt PE; Gabriel D; Garibaldi BT; Girvin AT; Guinney J; Hill EL; Hong SS; Jimenez H; Kavuluru R; Kostka K; Lehmann HP; Levitt E; Mallipattu SK; Manna A; McMurry JA; Morris M; Muschelli J; Neumann AJ; Palchuk MB; Pfaff ER; Qian Z; Qureshi N; Russell S; Spratt H; Walden A; Williams AE; Wooldridge JT; Yoo YJ; Zhang XT; Zhu RL; Austin CP; Saltz JH; Gersing KR; Haendel MA; Chute CG;
    JAMA Netw Open; 2021 Jul; 4(7):e2116901. PubMed ID: 34255046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary trace elements in association with disease severity and outcome in patients with COVID-19.
    Zeng HL; Zhang B; Wang X; Yang Q; Cheng L
    Environ Res; 2021 Mar; 194():110670. PubMed ID: 33387537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
    Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
    Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Characteristics and Risk Factors of Respiratory Failure in a Cohort of Young Patients Requiring Hospital Admission with SARS-CoV2 Infection in Spain: Results of the Multicenter SEMI-COVID-19 Registry.
    Díaz-Simón R; Lalueza A; Lora-Tamayo J; Rubio-Rivas M; Mendo CL; Martínez MLT; Méndez CA; Pesqueira Fontán PM; Cruz AF; Cabrera JLR; Rodríguez BC; Rubio AE; de Ávila VSR; García GMG; Osorio LC; González-Fernández M; Noya AG; Wittel MB; Fernandez FA; Sempere VM; Artero A; Loureiro-Amigo J; Huelgas RG; Santos JMA; Lumbreras C;
    J Gen Intern Med; 2021 Oct; 36(10):3080-3087. PubMed ID: 34379281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clinical outcomes in critically ill COVID-19 patients on mechanical ventilation with nosocomial pneumonia between Alpha and Omicron variants.
    Sun CY; Huang JR; Shen HC; Liao YT; Ko HJ; Chang CJ; Chen YM; Feng JY; Chen WC; Yang KY
    Ther Adv Respir Dis; 2023; 17():17534666231213642. PubMed ID: 38018405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
    Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
    Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
    Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical features and risk factors for secondary hemophagocytic lymphohistiocytosis in elderly patients with severe SARS-CoV-2 infection: a multicenter retrospective cohort study].
    Deng Y; Lu S; Zhang G; Sun W; Chu Y; Meng M; Cui Y; Li P
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):793-799. PubMed ID: 37593855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of clinical value of Xuebijing combined with human immunoglobulin in severe and critically ill patients with coronavirus disease 2019].
    Chen L; Zhang A; Li Q; Cui Y; Yuan G
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Apr; 33(4):399-404. PubMed ID: 34053480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics, Outcomes, and Severity Risk Factors Associated With SARS-CoV-2 Infection Among Children in the US National COVID Cohort Collaborative.
    Martin B; DeWitt PE; Russell S; Anand A; Bradwell KR; Bremer C; Gabriel D; Girvin AT; Hajagos JG; McMurry JA; Neumann AJ; Pfaff ER; Walden A; Wooldridge JT; Yoo YJ; Saltz J; Gersing KR; Chute CG; Haendel MA; Moffitt R; Bennett TD
    JAMA Netw Open; 2022 Feb; 5(2):e2143151. PubMed ID: 35133437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.